Basel Medical released FY2024 earnings on November 4 (EST), actual revenue USD 7.75 M, actual EPS USD 0.0947

Brief Summary

Basel Medical reported its 2024 fiscal year earnings with revenue of $7.75 million and an EPS of $0.0947 USD.

Impact of The News

Basel Medical’s financial report for the 2024 fiscal year shows a revenue of $7.75 million and an EPS of $0.0947 USD. To put these figures into context:

• Revenue: Basel Medical’s revenue of $7.75 million is a critical indicator of its market performance and growth. By comparing with other companies, such as Arm, which reported a revenue of $11.35 billion in Q2 2026 , and Apple’s revenue of $102.5 billion in Q4 2025 , it is evident that Basel Medical operates at a significantly smaller scale.
• EPS: The EPS reported by Basel Medical stands at $0.0947 USD. When juxtaposed with Ondas’ Q3 EPS of -$0.03 , Basel Medical’s profitability appears stronger, showcasing its ability to generate earnings for its shareholders.

This financial briefing suggests that Basel Medical is maintaining a steady business operation. However, its market position remains relatively modest compared to larger corporations. The positive EPS indicates efficient management and potential for future growth. Investors might watch for future updates to gauge the company’s trajectory in terms of scaling operations and enhancing profitability.